Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2007
02/14/2007CN1300143C Temozolomide refining process
02/14/2007CN1300142C Sulfonamide compounds and their production method and use
02/14/2007CN1300114C Phenylpyridine carbonyl piperazine derivative
02/13/2007US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
02/13/2007US7176312 Kinase inhibitor scaffolds and methods for their preparation
02/13/2007US7176311 Process for preparing pharmaceutically active compounds
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases
02/13/2007US7176210 Cannabinoid receptor ligands and uses thereof
02/13/2007US7176209 Fungicidal formulation
02/13/2007US7176203 Imidazo-triazine derivatives as ligands for gaba receptors
02/13/2007US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
02/13/2007US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/13/2007US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
02/13/2007US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same
02/13/2007CA2275191C Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen
02/08/2007WO2007016361A2 Novel pharmaceutical compounds
02/08/2007WO2007016155A2 Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
02/08/2007WO2007015866A2 Inhibitors of p38 kinase and methods of treating inflammatory disorders
02/08/2007WO2007015805A1 1-amino linked compounds
02/08/2007WO2007015414A1 OXADIAZOLE-SUBSTITUTED Sym-TRIINDOLE DERIVATIVE AND ORGANIC EL ELEMENT EMPLOYING THE SAME
02/08/2007WO2007015280A1 Benzodiazepine derivatives and uses thereof in medical field
02/08/2007WO2007014926A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014925A1 Macrocylic inhibitors of hepatitis c virus
02/08/2007WO2007014920A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014919A1 Macrocylic inhibitors of hepatitis c virus
02/08/2007WO2006135796A3 Crystalline forms of a pyrrolotriazine compound
02/08/2007WO2005103054A3 Bridged piperazine and piperidine derivatives as ccri antagonists
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032652 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure
02/08/2007US20070032651 Process for the preparation of carbostyril derivatives, such as aripiprazole and its intermediates
02/08/2007US20070032640 Cytokine receptor
02/08/2007US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis
02/08/2007US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
02/08/2007US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia
02/08/2007US20070032511 Amorphous ziprasidone mesylate
02/08/2007US20070032495 Pyrazolotriazines as kinase inhibitors
02/08/2007US20070032481 4-(4-fluoro-phenyl)-2-isopropyl-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidine; treatment or prevention of disease states mediated by 5-HT7 and/or 5-HT2 receptor
02/08/2007US20070032473 Substituted amides and their use as medicaments
02/08/2007US20070032469 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
02/08/2007US20070032418 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same
02/08/2007US20070028807 Heat-stable diketopyrrolopyrrole pigment mixtures
02/08/2007CA2617095A1 Macrocylic inhibitors of hepatitis c virus
02/07/2007EP1749009A1 Method for producing a solution of pure triethylenediamine (teda)
02/07/2007EP1749008A1 Bicyclic heterocycles as hiv integrase inhibitors
02/07/2007EP1749007A2 Macrocyclic compounds as inhibitors of viral replication
02/07/2007EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists
02/07/2007EP1678182B1 Process for preparing substituted 5-amino-pyrazolo- [4,3-e]-1,2,4-triazolo [1,5-c]pyrimidines
02/07/2007EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity
02/07/2007EP1392693B1 Triazolopyrimidines fungicides
02/07/2007EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
02/07/2007CN1910192A Metal complexes having vitamin B12 as a ligand
02/07/2007CN1910188A Use of phthalocyanines as marking substances for liquids
02/07/2007CN1910187A Triaza-cyclopenta [cd] indene derivatives
02/07/2007CN1910186A 6-(2-chloro-5-halophenyl)-triazolopyrimidine, method for production and use thereof for controlling fungal pests and agents comprising the same
02/07/2007CN1910185A Pyrrolopyrimidine and pyrrolotriazine derivatives as CRF receptor antagon
02/07/2007CN1910164A Organic compounds
02/07/2007CN1909908A Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
02/07/2007CN1298721C Method of separating, large scale preparing porphyrin from complex reaction system
02/07/2007CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method
02/07/2007CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions
02/07/2007CN1298715C Non-imidazole compounds as histamine H3 antagonists
02/07/2007CN1298704C Isatine derivatives with neurotrophic activity
02/07/2007CN1298323C Fused pyrrolocarbazoles against inflammation
02/06/2007US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts
02/06/2007US7173130 Detection of transmembrane potentials by optical methods
02/06/2007US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/06/2007US7173035 Arylsulfonamide compounds
02/06/2007US7173033 Nitrogen-containing heterocyclic compound
02/06/2007US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis
02/06/2007US7173031 Pyrrolotriazine kinase inhibitors
02/06/2007US7173029 Fused heteroaryl derivatives
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7173026 Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents
02/06/2007US7173023 Novel benzazepine derivatives as enzyme inhibitors of monoamine oxidase for disease treatment
02/06/2007US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides
02/06/2007US7173021 Anticancer agents, prodrugs for treatment on skins and basification
02/06/2007CA2411961C Novel process for the preparation of pyrazolopyrimidinones
02/01/2007WO2007014214A2 Introverted cucurbituril compounds
02/01/2007WO2007013964A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors
02/01/2007WO2007013691A1 Spiro-cyclic compound
02/01/2007WO2007013673A1 Fused heterocycles as lck inhibitors
02/01/2007WO2007012953A2 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
02/01/2007WO2007012642A1 7-amino-6-thiadiazolyl- and -oxadiazolyl- 1, 2, 4-triazolo [1, 5 -a] pyrimidine compounds and use thereof for the prevention of fungal pests
02/01/2007WO2007012603A1 Fungicide 6-phenyl-triazolopyrimidinyl amines
02/01/2007WO2007012602A1 Fungicide 5-methyl-6-phenyl-triazolopyrimidinyl amines
02/01/2007WO2007012601A1 6-phenyl-pyrazolopyrimidine-7-ylamine fungicides
02/01/2007WO2007012600A1 Fungicidal 5-alkyl-6-phenylpyrazolopyrimidin-7-ylamines
02/01/2007WO2007012599A1 Fungicidal 5-methyl-6-phenylpyrazolopyrimidin-7-ylamines
02/01/2007WO2007012464A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
02/01/2007WO2006086609A3 Inhibitors of tryptase
02/01/2007WO2006064205A3 Process for the preparation of a boron-substituted porphyrin
02/01/2007WO2005112919A3 Self-immolative linkers and drug conjugates
02/01/2007US20070027317 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
02/01/2007US20070027312 Methods and intermediates for the synthesis of porphyrins
02/01/2007US20070027311 Methods and intermediates for the synthesis of porphyrins
02/01/2007US20070027171 Cycloalkanepyrrolopyridines as dp receptor antagonists
02/01/2007US20070027166 Pyrazolo pyrimidines useful as aurora kinase inhibitors
02/01/2007US20070027156 Crf antagonists and heterobicyclic compounds